Market Research Reports

Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2011 - 2016

 

Description


The global vaccines market, which was once considered a commodity market, is now amongst the fastest growing markets of the pharmaceutical industry. This market forms about 3% of the global pharmaceutical industry. 

Driven by favorable demographics, product innovation, and rising public acceptance, the global vaccine market is worth more than US$25 billion.

Providing clients with an in-depth analysis and competitive intelligence about the global vaccine market, the research report evaluates in-depth all the important components of the market. Based on the holistic data presented by the report, businesses operating in the global vaccine market get an exhaustive overview of the vaccine market and can make informed business decisions.

The report also provides a huge store of information on market size, shares, growth rates, prevalent trends, and segments of the vaccine market. It also determines the major growth contributors, viable and emerging regional markets throughout the world. Along with this, the strengths and weaknesses of these regional markets, and the driving and inhibiting factors behind their market positions are also studied by the report.

In addition to this, the report outlines the competitive landscape of the global vaccine market by providing the financial overview, strategies and business outlook of the most important market players. Mergers and acquisitions, if any, occurring in the global vaccine market are also studied in-depth in the report.

Overview of the Global Vaccine Market
The global vaccines market has observed massive growth over the past few years, allowing it to outpace many traditional businesses in the pharmaceutical industry. The global vaccine market is currently facing many instances of mergers and acquisitions by leading pharmaceutical companies. As a result, the global vaccine market is steadily headed towards consolidation, leading to the dominance of a handful of major pharmaceutical companies.

The vaccine market operates under stringent cost constraints where profit margins keep continuously declining. Continuous technological advancements and progress of the biotechnology industry has further intensified the competitive nature of the global vaccine market.

Sustaining in such market conditions and gaining an edge amid the fiercely competitive market space requires market players to stay abreast through the introduction of innovative and cost-effective vaccines. Due to this, global vaccine manufacturers are investing substantial funds in research and development activities.

Rising incidences of epidemic of diseases such as Ebola, malaria, dengue, etc. have made the development of effective vaccines a worldwide concern. Rising awareness and initiatives taken by national bodies on a global front continue to present more growth potential for the global vaccine market.

The report states that four pharmaceutical companies – Pfizer, Sanofi, Novartis, and GlaxoSmithKline – together have a 74% share of the global vaccine market. Other major companies in the market compete for the remaining share of the market. 

Major geographies analyzed under this research report are: 
  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World 
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements in the micro servers industry
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents



1. Introduction

2. Executive Summary

3. Market Overview

a. Evolution of Vaccine Market

b. Global performance

c. Ongoing & Emerging trends

d. Global Initiatives & Funding

e. Investment Scenario

f.Major players

g. Competition Analysis

i.Market Share

ii. Investment Analysis

4. Market Metrics

a. Drivers

b. Challenges

c. Opportunities

5. Market Segmentation

a. By Product

i.Pediatric Vaccines

1. Product Categories

a. Polio

i.Market Size & Growth Rate

ii. Key trends

b. Pneumococcal

i.Market Size & Growth Rate

ii. Key trends

c. Varicella

i.Market Size & Growth Rate

ii. Key trends

d. Rotavirus

i.Market Size & Growth Rate

ii. Key trends

e. Meningococcal

i.Market Size & Growth Rate

ii. Key trends

f.DTP

i.Market Size & Growth Rate

ii. Key trends

g. Tuberclosis

i.Market Size & Growth Rate

ii. Key trends

h. Measles, Mumps & Rubella (MMR)

i.Market Size & Growth Rate

ii. Key trends

ii. Adult and Therapeutic Vaccines

1. Product Categories

a. Hepatitis B

i.Market Size & Growth Rate

ii. Key trends

b. Rabies

i. Market Size & Growth Rate

ii. Key trends

c. Typhoid

i.Market Size & Growth Rate

ii. Key trends

d. Cancer

i. Market Size & Growth Rate

ii. Key trends

e. Yellow Fever

i. Market Size & Growth Rate

ii. Key trends

f. Malaria

i. Market Size & Growth Rate

ii. Key trends

g. Influenza

i. Market Size & Growth Rate

ii. Key trends

h. Japanese Encephalitis

i. Market Size & Growth Rate

ii. Key trends

i. Typhoid

i. Market Size & Growth Rate

ii. Key trends

j. West Nile

i. Market Size & Growth Rate

ii. Key trends

k. HIV

i. Market Size & Growth Rate

ii. Key trends

b. By Geography

i. U.S Market

1. Market Overview

2. Market Size & Growth Rate

3. Market Metrics

a. Drivers

b. Challenges

c. Opportunities

4. Competition

II. Europe Market

1. Market Overview

2. Market Size & Growth Rate

3. Market Metrics

a. Drivers

b. Challenges

c. Opportunities

4. Competition

III. Asia-Pacific Market

1. Market Overview

2. Market Size & Growth Rate

3. Market Metrics

a. Drivers

b. Challenges

c. Opportunities

4. Competition

IV. Rest of the World (ROW) Market

1. Market Overview

2. Market Size & Growth Rate

3. Market Metrics

a. Drivers

b. Challenges

c. Opportunities

4. Competition

6. Competitive Landscape

a. Recent Developments

b. M&A/ other alliances

 
7. Patent Analysis

a. U.S

b. Europe

c. China

d. India

e. Japan

8. Company Profiles

a. Sanofi-Aventis

b. Novartis

c. GSK

d. Pfizer

Other players

NA

NA

Enquiry Before Buying


 
Pre Book Price: $4315.5 Original Price: $4795
Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research